• 学术搜索
  • 科研智能体
    • Research Labs
    • AI 阅读
    • AI 文库
    • 深度研究
    • 学者亮点
  • 学术资源
    • AI2000
    • 期刊/会议
    • 学者库
    • 学术API
      MCP&Skill
    • 溯源树
    • 数据集
  • 知识沉淀
    • 学术空间
订阅小程序
旧版功能
aminer vip
开通会员低至0.73元/天
一次搞定AI科研
立即登录
  • English
  • 联系方式
    The Open cancer immunology journal

    The Open cancer immunology journal

    JournalISSN 1876-4010eISSN 1876-4010

    年发文量

    研究主题

    论文(22)

    排序
    1Peripheral Blood Oxygen Saturation: A Non-invasive Prognostic Marker in Cancer Patients Treated with Radiation Therapy- A Pilot Study
    Savitha David,V Lokesh

    Aims: 1. To evaluate the prognostic value of SpO2 in cancer patients 2. To correlate between daily SpO2 values and tumor response to radiation. Background: Tumor hypoxia is an important prognostic factor in Oncology. It plays an important role in tumorogenesis, radiation resistance and tumor progression. Many invasive and in-vitro methods are available to assess the hypo-oxygenated status of tumors. Objective: We evaluated if SpO2 values measured from pulse oximetry could be used as an adjunct prognostic and predictive factor in oncology patients. Methods: Ten consecutive patients with locally advanced, non-metastatic disease were evaluated. Daily SpO2 measurements throughout the treatment and weekly haemoglobin values were noted. All patients received radical intent radiation therapy. Patients were categorised into two groups: poor SpO2 (<97mmHg) and better SpO2 (≥98mmHg). Results: Tumour response was higher in patients with better SpO2 (≥98mmHg). Patients with poor SpO2 (<97mmHg) presented with bulkier disease at diagnosis. Conclusion: Role of SpO2 as a prognostic and predictive factor should be explored further with in vitro and pH studies.

    2020引用:1
    引用
    AI阅读
    加入学术空间
    2Myeloid-derived Suppressor Cells in Cancer: A Review on the Pathogenesis and Therapeutic Potentials
    Seidu A. Richard

    Myeloid-Derived Suppressor Cells (MDSCs) are multifarious group of immature cells that arise from the myeloid and amass in individuals with cancer, sepsis, burns, or chronic inflammation. It has been evidenced that these group of cells are efficient in modifying adaptive and innate immune responses, coherent with their assumed key biological roles. It is evidenced that MDSCs inter-communicate with Tumor-Associated Macrophages (TAM), Tumor-Associated Neutrophils (TAN), Dendritic Cells (DCs), Receptor for Advanced Glycation End-products (RAGE), Toll-Like Receptors (TLRs), Matrix Metalloproteinase (MMPs) as well as High Mobility Group Box 1 (HMGB1) during carcinogenesis. This interaction although elaborated in various studies and reviews still does not explain in details as to how their interplay results in cancer pathogenesis. We noted that MDSC contributed to cancer immune suppression via TLR-4 receptor and lipopolysaccharideas (LPS). Furthermore, MDSC contributed to cancer development via MMPs (MMP-9 and MMP1-12) as well as RAGE. In the cancer microenvironment, HMGB1-driven MDSC amassment expedites cancer development and metastasis via PMN-MDSCs, macrophages, DCs and Immature Myeloid Cells (IMC). Also, HMGB1 intermediation with MDSCs via RAGE and/or TLR-4 leading to cancer development. Nevertheless, MDSCs have already proven potent in some cancers and are currently been used as treatment options although further studies are needed in some other cancers. Our review, therefore, explores the pivotal pathogenic and therapeutic roles of MDSCs in cancer.

    2018引用:1
    引用
    AI阅读
    加入学术空间
    3The Antitumor Immunity Mediated by NK Cells: the Role of the NCRs
    Mona Rady,Khaled Abou-Aisha

    Natural Killer (NK) cells are innate immune lymphocytes that are important for early and effective immune responses against infections and cancer. The antitumor immunity mediated by NK cells can be exerted through several direct or indirect “immunosurveillance” mechanisms that control tumor growth and prevent the rapid dissemination of metastatic tumors. NK cells express an array of activating and inhibitory receptors that enable them to recognize and bind non-self as well as self-ligands expressed on the surface of malignant or virally infected cells. The family of Natural Cytotoxicity Receptors (NCRs) comprises three activating receptors; NKp30, NKp44, and NKp46 that are important for the stimulation of NK cell effector functions. This review summarizes the mechanisms of antitumor immunity mediated by natural killer cells with focus on the role of the family of the NCRs and their tumor associated ligands.

    2018引用:1
    引用
    AI阅读
    加入学术空间
    4Nivolumab Induced Acute Severe Toxicity in Lung Adenocarcinoma
    Josune Azcuna Sagarduy,Eider Azkona Uribelarrea,Itziar Rubio Echevarria,Sergio Carrera Revilla,Alberto Muñoz Llarena,Guillermo López Vivanco

    Background: Immunotherapy has recently revolutionized the world of oncology. Nivolumab an IgG4 targeting PD-1 receptor has been approved in metastatic melanoma, renal cell carcinoma, Hodgkin lymphoma and non-small cell lung cancer. It works as a checkpoint inhibitor, allowing the immune system to clear cancer, and it is this mechanism of action which explains its toxicity also named as immmune-related adverse events. Case Presentation: This report describes the case of a 65-year-old female with metastatic lung adenocarcinoma treated with nivolumab. After 19º cycle she presented acute severe toxicity with pneumonitis, hypophisitis and thrombocytopenia. She was successfully treated with high dose steroids and immunoglobulins. Conclusion: Immune-related adverse events associated with nivolumab are usually nonspecific, with lots of differential diagnosis. They often resolve with prompt management, however, they may get severe if treatment is not retired and systemic immunosupression with corticosteroids is initiated. As shown in this case, we must be attentive throughout the treatment and even after the end of the treatment, since not all cases occur according to what is described in the literature.

    2018
    引用
    AI阅读
    加入学术空间
    5Transforming Growth Factor‐beta1 and Myeloid‐derived Suppressor Cells: A Cancerous Partnership
    Slavko Mojsilovic,Sonja S Mojsilovic,Suncica Bjelica,Juan F Santibanez

    Transforming growth factor-beta1 (TGF-β1) plays a crucial role in tumor progression. It can inhibit early cancer stages but promotes tumor growth and development at the late stages of tumorigenesis. TGF-β1 has a potent immunosuppressive function within the tumor microenvironment that largely contributes to tumor cells' immune escape and reduction in cancer immunotherapy responses. Likewise, myeloid-derived suppressor cells (MDSCs) have been postulated as leading tumor promoters and a hallmark of cancer immune evasion mechanisms. This review attempts to analyze the prominent roles of both TGF-β1 and MDSCs and their interplay in cancer immunity. Furthermore, therapies against either TGF-β1 or MDSCs, and their potential synergistic combination with immunotherapies are discussed. Simultaneous TGF-β1 and MDSCs inhibition suggest a potential improvement in immunotherapy or subverted tumor immune resistance.

    2017引用:78
    引用
    AI阅读
    加入学术空间
    立即登录,查看全部 22 篇论文

    高被引作者

    作者引用发文
    Slavko Mojsilovic1561
    Suncica Kapor Bjelica781
    Juan Francisco Santibañez781
    Douglas Feinstein302
    Roberta P. Glick262
    Vittoria Simonini Maria261
    Alexander Ksendzovsky261
    Paul Polak261
    Edward P. Cohen262
    Isako Saga231

    高产作者

    作者引用发文
    Terry Lichtor233
    Ocadlikova Darina232
    Edward P. Cohen262
    Jing Ni42
    Roberta P. Glick262
    Volker Schirrmacher42
    Douglas Feinstein302
    Philippe Fournier42
    Roman Hájek232
    abdullah kasim althobhani201

    相关期刊

    Acta neuropathologica. Supplementum
    Annals of tropical paediatrics
    Current trends in microbiology
    Journal of inflammatory bowel diseases & disorders
    Endocrinology, diabetes and metabolism journal
    Cancer studies and therapeutics
    Research Journal of Seed Science
    Lung biology in health and disease
    Clinical and Translational Discovery
    Exploration of Immunology